A ‘Best Practice’: ACRO, Pharma Respond to FDA Draft Guidance as RBM Adoption Increases Posted on May 30, 2019June 21, 2021 by Hannah Faulkner A ‘Best Practice’: ACRO, Pharma Respond to FDA Draft Guidance as RBM Adoption Increases
